June 19, 2020 / 11:32 AM / a month ago

BRIEF-Emerald Health Posts Quarterly Net Sales Of $2.9 Million, Up 36%

June 19 (Reuters) - Emerald Health Therapeutics Inc:

* EMERALD HEALTH THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* EMERALD HEALTH- NET SALES OF $2.9M INCREASED 36% IN QUARTER

* EMERALD HEALTH- Q1 NET LOSS OF $4.9 MILLION INCLUDES $2.0 MILLION LOSS ON DILUTION OF JV OWNERSHIP, $1.1M INVENTORY WRITE-DOWN

* EMERALD HEALTH- DUE DILIGENCE PROCESS OF AGREEMENT WITH SIGMA ANALYTICAL SERVICES INC HAS BEEN DELAYED DUE TO COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below